Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/18/24 11:40 | 9/16/24 | EMMA | Health | Drug | Pharmaceutical Preparations | Lim Seah H. | CA | D | P | 1 | 0.0400 | 0 | 20 | 0 | 4,607 | D | |||||||||||||||
2/29/24 18:11 | 2/26/24 | EMMA | Health | Drug | Pharmaceutical Preparations | Lee Willis C | CA | DO | Co-P,COO | P.m | 15 | 0.1276 | 0 | 115 | 17 | 796 | I | ||||||||||||||
1/3/24 16:59 | 8/25/23 | EMMA | Health | Drug | Pharmaceutical Preparations | Lee Willis C | CA | DO | COO | P.am | 15 | 0.1263 | 0 | 121 | 22 | 681 | M | ||||||||||||||
12/19/23 19:44 | 10/9/22 | EMMA | Health | Drug | Pharmaceutical Preparations | Lim Seah H. | CA | D | P.dm | 31 | 0.2221 | 0 | 139 | 3 | 4,619 | D | |||||||||||||||
12/4/23 20:33 | 8/25/23 | EMMA | Health | Drug | Pharmaceutical Preparations | Lee Willis C | CA | DO | COO | P.m | 2 | 0.1296 | 0 | 16 | 2 | 681 | M | ||||||||||||||
6/2/23 13:23 | 9/20/22 | EMMA | Health | Drug | Pharmaceutical Preparations | Lee Willis C | CA | DO | COO | P.m | 9 | 0.2897 | 0 | 29 | 6 | 560 | M | ||||||||||||||
12/1/22 13:35 | 11/3/22 | EMMA | Health | Drug | Pharmaceutical Preparations | Niihara Yutaka | CA | DOT | CB,CEO | P.m | 21 | 0.4035 | 0 | 53 | 0 | 12,197 | D | ||||||||||||||
11/3/22 14:50 | 10/31/22 | EMMA | Health | Drug | Pharmaceutical Preparations | Niihara Yutaka | CA | DOT | CB,CEO | P.m | 12 | 0.4355 | 0 | 28 | 0 | 12,144 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |